Nevertheless, our study represents the first investigation into the levels of anti-C3aR and anti-C5aR antibodies in glomerular diseases, revealing an association between the clinical development of lupus nephropathy and focal and segmental glomerulosclerosis and antibody levels. Here, C5AR1 is linked to focal segmental glomerulosclerosis.